This Cannabis Stock Is Down 40%: Read This Before You Buy

When I published that Hexo Corp (TSX:HEXO) was my top cannabis stock for 2019, timing was on my side.

Shares have risen by more than 50% since that call, fueled by the rapid inflow of capital into the cannabis sector. Indeed, a rising tide lifts all boats.

With nearly every cannabis stock up big since 2019 began, many investors are searching for companies that have been left out of the race. Down 40% on the year, many bargain shoppers are sniffing around Namaste Technologies Inc (TSXV:N) stock.

Is Namaste a hidden value in a red-hot industry? Let’s compare it to Hexo Corp to find out.

Here’s the big difference

Namaste Technologies doesn’t grow marijuana. Nearly every other pot stock does.

For example, Hexo just opened its 1,000,000-square-foot growing facility. Production should slowly ramp this quarter, ideally reaching full capacity by the end of 2019. With licenses and purchasing agreements with many of Canada’s provinces, Hexo has a clear path to grow revenues and cash flow quickly.

Namaste is in no such position given that it’s basically an e-commerce business that sells hardware and accessories like vaporizers. It also has a nascent telemedicine app which aims to serve medical marijuana patients.

According to a Motley Fool exclusive, the app provides “a free virtual consultation with a licensed health-care professional to obtain a prescription for medical cannabis. From there, NamasteMD then gives patients several options to fill their prescription and buy medical cannabis.”

Hardware and software for the burgeoning marijuana industry could still result in big business, but it’s critical to note Namaste’s strategic differences.

What’s not to like?

Namaste has already secured nearly a dozen medical cannabis providers as clients. One of its most recent deals gave it leading sales access to the 1.5 million strong indigenous population. Management wants to hit 200,000 patients by the end of this year.

How do these developments lead to a 40% drop in share price?

With a market capitalization just over $200 million, Namaste is now one of the smallest cannabis stocks left on the market. Unfortunately, it probably deserves this valuation.

In October, short-seller Citron Research release a damning report that called Namaste a “complete fraud.” The research organization essentially accused Namaste’s CEO of a pump-and-dump scheme, saying it made a “fake claim of a Nasdaq Inc listing to get investors to buy the stock.”

A few months later, following an investigation, Namaste’s board of directors fired the CEO in question.

This stock is a mess

At this point, it’s difficult to sort out fact from truth for Namaste.

In February, its board of directors revealed that it would “consider all value-maximizing alternatives” to the company’s future. Most investors took that as a signal that Namaste would attempt selling itself completely, a difficult pill to swallow give its rock-bottom valuation following the executive scandal.

Either way, this is not the pot stock you want to buy. While shares of Hexo give you a de-risked way to directly profit from rising cannabis sales, Namaste is a significantly more complex story. All that it has at this point is an association with the cannabis industry—that’s not enough to earn my investment.

You might be missing out on one of the biggest opportunities in Canadian investing history…

Marijuana was legalized across Canada on October 17th, and a little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

Besides making key partnerships with Facebook and Amazon, they’ve just made a game-changing deal with the Ontario government.

One grassroots Canadian company has already begun introducing this technology to the market – which is why legendary Canadian investor Iain Butler thinks they have a leg up on Amazon in this once-in-a-generation tech race.

This is the company we think you should strongly consider having in your portfolio if you want to position yourself wisely for the coming marijuana boom.

Learn More About This TSX Stock Now

More reading

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

Source: The Fool
This Cannabis Stock Is Down 40%: Read This Before You Buy
The Fool

The Motley Fool
Contributor for
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related posts